IFF Health’s Sharp-PS ingredient has been notified and listed in Australia and New Zealand for brain health and cognition claims
IFF Health's soy phosphatidylserine ingredient has been notified and listed in Australia and New Zealand for brain health and cognition claims. The Food Standards Australia New Zealand (FSANZ) authority has listed claims for soy phosphatidylserine from Sharp-PS based on acceptance of the self-notification process.
The claims listed relate to the relationship between consumption of Sharp-PS phosphatidylserine (PS) through food products and "Maintenance and/or improvement of cognitive function and brain health". Based on this listing, food companies can now include the IFF (formerly Frutarom Health) ingredient with this claim.
Itay Shafat, Product Manager for Cognitive Line, IFF Health explained that Phosphatidylserine is ideal for inclusion into food and beverage matrices, as it has no taste or smell and does not affect mouthfeel.
“The benefits of PS consumption have been demonstrated in numerous clinical and pre-clinical studies, leading FSANZ to link its consumption to these benefits,” said Itay Shafat, Product Manager for Cognitive Line, IFF Health. “As the interest in brain health and cognitive capabilities continues to rise within the ageing global population, the timing of this approval could not have been better.”
With global trends such as the ageing population and an increase in brain-health awareness, “pill-fatigued” consumers are actively seeking alternative delivery formats for their health ingredients.